These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2042654)

  • 1. Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide.
    Coburn JW; Mischel MG; Goodman WG; Salusky IB
    Am J Kidney Dis; 1991 Jun; 17(6):708-11. PubMed ID: 2042654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of calcium acetate or calcium citrate on intestinal aluminum absorption.
    Nolan CR; Califano JR; Butzin CA
    Kidney Int; 1990 Nov; 38(5):937-41. PubMed ID: 2266679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum and lead absorption from dietary sources in women ingesting calcium citrate.
    Nolan CR; DeGoes JJ; Alfrey AC
    South Med J; 1994 Sep; 87(9):894-8. PubMed ID: 8091252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oral bases on enteral aluminum absorption.
    Walker JA; Sherman RA; Cody RP
    Arch Intern Med; 1990 Oct; 150(10):2037-9. PubMed ID: 2171446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers.
    Priest ND; Talbot RJ; Austin JG; Day JP; King SJ; Fifield K; Cresswell RG
    Biometals; 1996 Jul; 9(3):221-8. PubMed ID: 8696074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium citrate without aluminum antacids does not cause aluminum retention in patients with functioning kidneys.
    Sakhaee K; Wabner CL; Zerwekh JE; Copley JB; Pak L; Poindexter JR; Pak CY
    Bone Miner; 1993 Jan; 20(1):87-97. PubMed ID: 8453325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcium supplement preparation containing small amounts of citrate on the absorption of aluminium in normal subjects and in renal failure patients.
    Nestel AW; Meyers AM; Paiker J; Rollin HB
    Nephron; 1994; 68(2):197-201. PubMed ID: 7830856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of oral bases on aluminum absorption.
    Mauro LS; Kuhl DA; Kirchhoff JR; Mauro VF; Hamilton RW
    Am J Ther; 2001; 8(1):21-5. PubMed ID: 11304654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperaluminemia in renal failure: the influence of age and citrate intake.
    Bakir AA; Hryhorczuk DO; Ahmed S; Hessl SM; Levy PS; Spengler R; Dunea G
    Clin Nephrol; 1989 Jan; 31(1):40-4. PubMed ID: 2914409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orange juice enhances aluminium absorption from antacid preparation.
    Fairweather-Tait S; Hickson K; McGaw B; Reid M
    Eur J Clin Nutr; 1994 Jan; 48(1):71-3. PubMed ID: 8200332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of aluminium-containing antacid absorption in man.
    Nagy E; Jobst K
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):119-21. PubMed ID: 8031961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminum-citrate interaction in end-stage renal disease.
    Rudy D; Sica DA; Comstock T; Davis J; Savory J; Schoolwerth AC
    Int J Artif Organs; 1991 Oct; 14(10):625-9. PubMed ID: 1748529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lack of influence of long-term potassium citrate and calcium citrate treatment in total body aluminum burden in patients with functioning kidneys.
    Sakhaee K; Ruml L; Padalino P; Haynes S; Pak CY
    J Am Coll Nutr; 1996 Feb; 15(1):102-6. PubMed ID: 8632109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary citric acid enhances absorption of aluminum in antacids.
    Slanina P; Frech W; Ekström LG; Lööf L; Slorach S; Cedergren A
    Clin Chem; 1986 Mar; 32(3):539-41. PubMed ID: 3948402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids.
    Kirschbaum BB; Schoolwerth AC
    Am J Med Sci; 1989 Jan; 297(1):9-11. PubMed ID: 2913801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal absorption and urinary excretion of aluminium in patients with predialysis chronic renal failure.
    Nordal KP; Dahl E; Sørhus K; Berg KJ; Thomassen Y; Kofstad J; Halse J
    Pharmacol Toxicol; 1988 Nov; 63(5):351-4. PubMed ID: 3237594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can aluminium-containing antacid produce dementia?
    Jobst K; Nagy J
    Nephron; 1995; 71(4):473. PubMed ID: 8587635
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in plasma and tissue aluminum concentrations due to different aluminum-containing drugs in patients with renal insufficiency and with normal renal function.
    Winterberg B; Bertram H; Rolf N; Roedig M; Kisters K; Remmers S; Spieker C; Zumkley H
    J Trace Elem Electrolytes Health Dis; 1987 Dec; 1(2):69-72. PubMed ID: 2856571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB; Foley J; Nelson P; Goodman WG
    N Engl J Med; 1991 Feb; 324(8):527-31. PubMed ID: 1992306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperaluminaemia in critically ill patients: role of antacid therapy and impaired renal function.
    Ittel TH; Gladziwa U; Mück W; Sieberth HG
    Eur J Clin Invest; 1991 Feb; 21(1):96-102. PubMed ID: 1907560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.